CARGO Therapeutics (CRGX) Company Overview

Profile

Full Name:

CARGO Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 13, 2023

Indexes:

Not included

Description:

CARGO Therapeutics (CRGX) focuses on developing innovative therapies for cancer treatment. The company specializes in engineered T-cell therapies, aiming to enhance the immune system's ability to target and destroy cancer cells, offering new hope for patients with difficult-to-treat cancers.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 25 William Blair
Market Perform
Jan 30, 25 Truist Securities
Hold
Jan 30, 25 Piper Sandler
Neutral
Jan 30, 25 Jefferies
Hold
Jan 30, 25 JP Morgan
Underweight
Jan 30, 25 HC Wainwright & Co.
Neutral
Jan 30, 25 Chardan Capital
Neutral
Nov 26, 24 William Blair
Outperform
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Chardan Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for CARGO Therapeutics?
  • Does CARGO Therapeutics pay dividends?
  • What sector is CARGO Therapeutics in?
  • What industry is CARGO Therapeutics in?
  • What country is CARGO Therapeutics based in?
  • When did CARGO Therapeutics go public?
  • Is CARGO Therapeutics in the S&P 500?
  • Is CARGO Therapeutics in the NASDAQ 100?
  • Is CARGO Therapeutics in the Dow Jones?
  • When was CARGO Therapeutics's last earnings report?
  • When does CARGO Therapeutics report earnings?
  • Should I buy CARGO Therapeutics stock now?

What is the ticker symbol for CARGO Therapeutics?

The ticker symbol for CARGO Therapeutics is NASDAQ:CRGX

Does CARGO Therapeutics pay dividends?

No, CARGO Therapeutics does not pay dividends

What sector is CARGO Therapeutics in?

CARGO Therapeutics is in the Healthcare sector

What industry is CARGO Therapeutics in?

CARGO Therapeutics is in the Biotechnology industry

What country is CARGO Therapeutics based in?

CARGO Therapeutics is headquartered in United States

When did CARGO Therapeutics go public?

CARGO Therapeutics's initial public offering (IPO) was on November 13, 2023

Is CARGO Therapeutics in the S&P 500?

No, CARGO Therapeutics is not included in the S&P 500 index

Is CARGO Therapeutics in the NASDAQ 100?

No, CARGO Therapeutics is not included in the NASDAQ 100 index

Is CARGO Therapeutics in the Dow Jones?

No, CARGO Therapeutics is not included in the Dow Jones index

When was CARGO Therapeutics's last earnings report?

CARGO Therapeutics's most recent earnings report was on Nov 12, 2024

When does CARGO Therapeutics report earnings?

The next expected earnings date for CARGO Therapeutics is Mar 21, 2025

Should I buy CARGO Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions